-
Management Board: Highlights of October 2023 meeting
Management Board: Highlights of October 2023 meeting
-
Management Board: Highlights of October 2023 meeting
Management Board: Highlights of October 2023 meeting
The Board adopted revised transparency rules for the Clinical Trials Information System and was updated on EMA’s activities in the first half of 2023
-
Revision of transparency rules for clinical trials
Revision of transparency rules for clinical trials
-
Revision of transparency rules for clinical trials
Revision of transparency rules for clinical trials
EMA revised rules to give faster access to information in the EU Clinical Trials Information System
-
Highlights of the safety committee: October 2023
Highlights of the safety committee: October 2023
-
Highlights of the safety committee: October 2023
Highlights of the safety committee: October 2023
At its monthly meeting, EMA's safety committee, the PRAC, discussed new safety information for medicines containing omega-3-acid ethyl esters
-
New ACT EU video released
New ACT EU video released
-
New ACT EU video released
New ACT EU video released
Watch a video to learn about how the Accelerating Clinical Trials in the EU (ACT EU) initiative is transforming the way clinical trials are initiated, designed, and run
Information for you
Key content
Services & databases
-
List item
Clinical Trials website
-
List item
Account Management portal
-
List item
eSubmission
-
List item
EudraVigilance (human)
-
List item
EudraVigilance Veterinary
-
List item
Veterinary Medicines information website
-
List item
Suspected adverse drug reactions database
-
List item
Clinical data
-
List item
SPOR data management services
-
List item
Service Desk
-
List item
IRIS platform
-
List item
Public register of parallel distribution notices
-
List item
European Vaccination Information Portal